朴炳奎滋阴补肾、解毒化瘀法治疗肾癌一则
A Case Study on Treatment of Kidney Cancer by Professor PIAO Bingkui with Nourishing Yin and Tonifying Kidney and Removing Toxin and Resolving Stasis
扫 描 看 全 文
1.中国中医科学院广安门医院肿瘤科,北京 100053
扫 描 看 全 文
朴炳奎, 周雍明, 郑红刚, 等. 朴炳奎滋阴补肾、解毒化瘀法治疗肾癌一则[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29999625&Fpath=home&index=0
PIAO Bingkui, ZHOU Yongming, ZHENG Honggang, et al. A Case Study on Treatment of Kidney Cancer by Professor PIAO Bingkui with Nourishing Yin and Tonifying Kidney and Removing Toxin and Resolving Stasis[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29999625&Fpath=home&index=0
朴炳奎, 周雍明, 郑红刚, 等. 朴炳奎滋阴补肾、解毒化瘀法治疗肾癌一则[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29999625&Fpath=home&index=0 DOI:
PIAO Bingkui, ZHOU Yongming, ZHENG Honggang, et al. A Case Study on Treatment of Kidney Cancer by Professor PIAO Bingkui with Nourishing Yin and Tonifying Kidney and Removing Toxin and Resolving Stasis[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29999625&Fpath=home&index=0 DOI:
病史摘要,2,患者许某,女,74岁,主因“无痛性肉眼血尿3月余”就诊。患者于3个月前出现无痛性肉眼血尿,无发热及尿频、尿急等症状,于复兴医院查腹部CT示右肾占位,大小4 cm×5 cm,考虑肿瘤;胸片及B超检查未见远处转移。随后在中国医学科学院肿瘤医院行右肾癌切除术,术后病理示乳头状移行细胞癌,淋巴结转移2/7,恶性肿瘤国际临床病期分类(TNM)分期:T1bN1M0。术后未行放化疗、靶向治疗等其他治疗。中医诊断 肾积(阴虚毒蕴证)。西医诊断 右肾癌全切除术后,乳头状腺癌。干预措施 注重补益脾肾亏虚,兼顾清除毒邪,合用西黄解毒胶囊及软坚消瘤片,加强祛邪之力。疗效转归 患者服用一段时间后诸症均减,血常规恢复正常,体力得到增加,提高了生活质量,获得了长期总生存(OS)=3年。
Summary of case history ,XU, female, 74 years old, went to the hospital because of "Painless gross hematuria for more than 3 months". The patient developed painless gross hematuria 3 months ago, without fever, frequent urination, urgency and other symptoms. The abdominal CT scan in Fuxing Hospital showed that the right kidney occupies 4 cm×5 cm in size, and tumor was considered, chest X-ray and B-ultrasound showed no evidence. Distant metastasis. Subsequently, right nephrectomy was performed in the Cancer Hospital of the Chinese Academy of Medical Sciences. The postoperative pathology showed papillary transitional cell carcinoma and lymph node metastasis in 2/7, T1bN1M0. No other treatments such as radiotherapy, chemotherapy and targeted therapy after surgery.,TCM diagnosis ,Nephrosis (Yin Deficiency and Toxin Accumulation).,Western medicine diagnosis, Papillary adenocarcinoma after total right renal resection.,Therapeutic methods ,Pay attention to replenishing the deficiency of the spleen and kidney, and take into account the elimination of toxins. Xihuang Jiedu capsules and Ruanjian Xiaoliu tablets are used together to strengthen the power of eliminating pathogens.,Clinical outcomes, After taking the drug for a period of time, all symptoms were reduced, blood routine returned to normal, physical strength was increased, quality of life was improved, and long-term survival (OS=3 years) was achieved.
朴炳奎肾癌中医药中西医结合治疗泌尿
PIAO Bingkuikidney cancerChinese medicineintegrated Chinese and western medicine treatmentnephrology
Bindayi A,Hamilton Z A,Mcdonald M L,et al. Neoadjuvant therapy for localized and locally advancedrenal cell carcinoma[J].Urol Oncol,2018,36(1):31-37.
Znaor A,Lortet-tieulent J,Laversanne M,et al.International variations and trends in renal cell carcinoma incidence and mortality[J].Eur Urol,2015,67(3):519-530.
Mohammadian M,Pakzad R,Towhidi F,et al. Incidence and mortality of kidney cancer and its relationship with HDI(Human Development Index)in the world in 2012[J]. Clujul Medical,2017,90(3):286-293.
张弛,李菁,林丽珠.林丽珠辨治肾癌经验探析[J].中医肿瘤学杂志,2019,1(5):59-63.
Papac R J,Keohane M F.Hormonal therapy for metastatic renal cell carcinoma combined and rogen and provera followed by high dose tamoxifen.Eur J Cancer,1993,29A(7):997-999.
张孝刚,胡帅航,等.朴炳奎治疗肿瘤常用药组探析[J].中医杂志,2021,62(16):1395-1399.
高铭哲,李婷,田晨琪,等.肉桂化学成分与药理作用研究进展[J].亚太传统医药,2021,17(11):201-205.
0
浏览量
11
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构